Cargando…
Challenges and Lessons Learned From COVID-19 Trials: Should We Be Doing Clinical Trials Differently?
The COVID-19 crisis led to a flurry of clinical trials activity. The COVID-evidence database shows 2814 COVID-19 randomized trials registered as of February 16, 2021. Most were small (only 18% have a planned sample size > 500) and the rare completed ones have not provided published results prompt...
Autores principales: | Janiaud, Perrine, Hemkens, Lars G., Ioannidis, John P.A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Canadian Cardiovascular Society. Published by Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8164884/ https://www.ncbi.nlm.nih.gov/pubmed/34077789 http://dx.doi.org/10.1016/j.cjca.2021.05.009 |
Ejemplares similares
-
Recruitment and Results Reporting of COVID-19 Randomized Clinical Trials Registered in the First 100 Days of the Pandemic
por: Janiaud, Perrine, et al.
Publicado: (2021) -
Clinical trial research agenda on COVID-19 – the first two years in Germany and beyond
por: Hirt, Julian, et al.
Publicado: (2022) -
Randomized trials on non-pharmaceutical interventions for COVID-19: a scoping review
por: Hirt, Julian, et al.
Publicado: (2022) -
Meta-research on pragmatism of randomized trials: rationale and design of the PragMeta database
por: Hirt, Julian, et al.
Publicado: (2023) -
Real-world evidence: How pragmatic are randomized controlled trials labeled as pragmatic?
por: Dal-Ré, Rafael, et al.
Publicado: (2018)